You are here: Industry Insights > Sanofi

News List

Sanofi, Google link up for new healthcare innovation lab pharmatimes
June 18, 2019
Sanofi and Google have announced a joint virtual Innovation Lab, with the aim to “radically transform how future medicines and health services are delivered by tapping into the power of emerging data technologies.”
Voyager Therapeutics, Sanofi Genzyme Restructure Gene Therapy Alliance contractpharma
June 18, 2019
Voyager gains worldwide rights to VY-HTT01 Huntington’s disease program and ex-U.S. rights to VY-FXN01 Friedreich’s ataxia program for $10 million upfront.
Enable Injections Enters into Partnership with Sanofi contractpharma
June 12, 2019
Enable's enFuse delivers high-volume therapeutics outside of the clinical setting.
Sales Awards finalists give their thoughts on the competition pharmatimes
June 11, 2019
The prestigious PharmaTimes Sales Awards are recognised for their highly beneficial and rewarding challenges, and last year’s finalists and winners have chipped in to explain what’s so great about the process.
Sanofi Names New CEO contractpharma
June 10, 2019
Paul Hudson to succeed Olivier Brandicourt as of September 1st.
Sanofi, Regeneron dive deep on asthma in debut digital awareness campaign fiercepharma
June 05, 2019
Most people know what asthma is, but even asthma patients can underestimate it. Sanofi and Regeneron’s new online disease awareness campaign highlights the problems of uncontrolled asthma.
Sanofi gets EC approval for Dupixent to treat severe asthma pharmaceutical-technology
May 10, 2019
Sanofi’s Dupixent has been approved by the European Commission (EC) as an add-on maintenance treatment for severe asthma in adults and adolescents.
EU approval for Sanofi’s type 2 diabetes treatment europeanpharmaceuticalreview
May 08, 2019
Suliqua is an innovative new combination therapy that has the potential to address significant unmet needs for people living with type 2 diabetes in Europe
EU approval for Regeneron and Sanofi’s rheumatoid arthritis drug europeanpharmaceuticalreview
May 07, 2019
The European Commission (EC) has granted marketing authorisation for Regeneron and Sanofi’s Kevzara (sarilumab) for the treatment of rheumatoid arthritis…
Sanofi’s dengue vaccine secures FDA approval pharmaceutical-technology
May 06, 2019
Sanofi has received approval from the US Food and Drug Administration (FDA) for Dengvaxia, a vaccine that is designed to prevent all four dengue disease serotypes.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page